One key area of interest in cardiovascular endocrinology is the impact of metabolic syndrome on cardiovascular health. Metabolic syndrome, characterized by a cluster of conditions such as obesity, insulin resistance, and dyslipidemia, significantly increases the risk of cardiovascular diseases. Cardiovascular endocrinologists study the intricate relationships between adipose tissue, insulin signaling, and inflammation, exploring how these factors contribute to the development of atherosclerosis and cardiovascular complications. Research in cardiovascular endocrinology also delves into hormonal regulation of blood pressure, focusing on the role of aldosterone, renin-angiotensin-aldosterone system (RAAS), and other hormones in maintaining cardiovascular homeostasis. The integration of endocrinology and cardiovascular medicine highlights the need for a comprehensive understanding of the interactions between hormonal regulation and cardiovascular function, paving the way for targeted therapies and personalized approaches to address the multifaceted aspects of cardiovascular health.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain